Jochen Decaestecker

943 total citations
22 papers, 283 citations indexed

About

Jochen Decaestecker is a scholar working on Oncology, Hepatology and Epidemiology. According to data from OpenAlex, Jochen Decaestecker has authored 22 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Jochen Decaestecker's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (5 papers) and Liver Disease and Transplantation (4 papers). Jochen Decaestecker is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (5 papers) and Liver Disease and Transplantation (4 papers). Jochen Decaestecker collaborates with scholars based in Belgium, United States and Canada. Jochen Decaestecker's co-authors include Frederik Nevens, Johan Fevery, Jacques Pirenne, Aezam Katoonizadeh, Tania Roskams, Raymond Aerts, P Yap, Chris Verslype, Alexander Wilmer and Sylvie Breton and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Jochen Decaestecker

21 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jochen Decaestecker Belgium 9 146 120 51 45 44 22 283
Liang Tang China 12 82 0.6× 65 0.5× 56 1.1× 6 0.1× 16 0.4× 22 332
Haruhiko Inatsu Japan 13 24 0.2× 94 0.8× 94 1.8× 12 0.3× 51 1.2× 22 429
D. Degiorgio Italy 12 72 0.5× 103 0.9× 195 3.8× 6 0.1× 191 4.3× 13 382
Máté G. Kiss Austria 6 31 0.2× 94 0.8× 29 0.6× 4 0.1× 6 0.1× 18 278
Shana White United States 6 60 0.4× 60 0.5× 117 2.3× 10 0.2× 102 2.3× 9 267
Toshihiro Kawai Japan 7 168 1.2× 94 0.8× 84 1.6× 1 0.0× 57 1.3× 19 360
Soichiro Kawata Japan 10 34 0.2× 50 0.4× 128 2.5× 8 0.2× 145 3.3× 26 279
Sam Zakhari United States 7 53 0.4× 95 0.8× 58 1.1× 2 0.0× 25 0.6× 10 252
Toshiya Tanaka Japan 8 15 0.1× 19 0.2× 181 3.5× 9 0.2× 102 2.3× 31 306

Countries citing papers authored by Jochen Decaestecker

Since Specialization
Citations

This map shows the geographic impact of Jochen Decaestecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Decaestecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Decaestecker more than expected).

Fields of papers citing papers by Jochen Decaestecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen Decaestecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Decaestecker. The network helps show where Jochen Decaestecker may publish in the future.

Co-authorship network of co-authors of Jochen Decaestecker

This figure shows the co-authorship network connecting the top 25 collaborators of Jochen Decaestecker. A scholar is included among the top collaborators of Jochen Decaestecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jochen Decaestecker. Jochen Decaestecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Decaestecker, Jochen, et al.. (2026). “Effect of direct oral anticoagulants in cirrhosis: an in vitro study”: comment. Journal of Thrombosis and Haemostasis. 24(3). 1197–1202.
2.
Raevens, Sarah, Jochen Decaestecker, Lieve Van Hoof, et al.. (2024). Unravelling the coagulation paradox in liver cirrhosis: challenges and insights. Acta Clinica Belgica. 79(6). 451–461. 1 indexed citations
3.
Vanhoutte, Greetje, Willem Lybaert, Wim Demey, et al.. (2023). NPY Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer. Clinical Cancer Research. 29(9). 1741–1750. 12 indexed citations
4.
Jacquet, Aurélie de Rus, Melanie Alpaugh, Hélèna L. Denis, et al.. (2023). The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease. Nature Communications. 14(1). 3651–3651. 69 indexed citations
5.
Bourgeois, Stefan, Mike Cool, Xavier Verhelst, et al.. (2021). Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium : an observational study. Acta Gastro Enterologica Belgica. 84(1). 33–41. 1 indexed citations
7.
Wulf, Dominiek De, et al.. (2020). Transjugular intrahepatic portosystemic shunt placement for symptomatic non- bleeding anorectal varices in nodular regenerative hyperplasia.. PubMed. 83(2). 331–333. 1 indexed citations
8.
Aerts, Marc, et al.. (2018). An explorative study on systematic assessment of QOL and care needs with the CARES-SF in the early follow-up of patients with digestive cancer. Supportive Care in Cancer. 27(7). 2715–2724. 1 indexed citations
10.
Bielen, Rob, Christophe Moreno, Hans Van Vlierberghe, et al.. (2017). Belgian experience with direct acting antivirals in people who inject drugs. Drug and Alcohol Dependence. 177. 214–220. 19 indexed citations
11.
Bielen, Rob, Christophe Moreno, Hans Van Vlierberghe, et al.. (2017). The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C‐infected patients treated with direct‐acting antivirals with and without pegylated interferon: A Belgian experience. Journal of Viral Hepatitis. 24(11). 976–981. 35 indexed citations
12.
13.
Leroy, Jules G., Priya S. Kishnani, Jochen Decaestecker, et al.. (2016). New observation of sialuria prompts detection of liver tumor in previously reported patient. Molecular Genetics and Metabolism. 118(2). 92–99. 2 indexed citations
15.
Abella, Steve, Alvydas Česas, Adina Croitoru, et al.. (2013). Results of a phase III, randomized, double-blind, placebo-controlled trial of pegfilgrastim (PEG) in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab (B) for colorectal cancer (CRC).. Journal of Clinical Oncology. 31(4_suppl). LBA445–LBA445. 4 indexed citations
16.
D’Heygere, F, C. George, Hans Van Vlierberghe, et al.. (2011). Efficacy of interferon‐based antiviral therapy in patients with chronic hepatitis C infected with genotype 5: A meta‐analysis of two large prospective clinical trials. Journal of Medical Virology. 83(5). 815–819. 11 indexed citations
17.
Cutsem, Eric Van, André D’Hoore, Christophe De Vleeschouwer, Jochen Decaestecker, & Freddy Penninckx. (2008). Colon cancer: management of locoregional disease. 1 indexed citations
18.
Katoonizadeh, Aezam, Jochen Decaestecker, Alexander Wilmer, et al.. (2007). MELD score to predict outcome in adult patients with non‐acetaminophen‐induced acute liver failure. Liver International. 27(3). 329–334. 74 indexed citations
19.
Penninckx, Freddy, Sarah Roels, Daniel Léonard, et al.. (2007). Kwaliteit van rectale kankerzorg, fase 1. 1 indexed citations
20.
Decaestecker, Jochen, et al.. (2006). Endoscopic treatment of an iatrogenic perforation of the colon by using endoloop. Gastrointestinal Endoscopy. 64(4). 653–654. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026